The COVID-19 patients who died had significantly higher percentage of circulating angiogenic neutrophils (Fig. 5a) as well as lower expression of VEGF-R1 (Fig. 5b) associated with higher soluble VEGF-1 (Fig. 5c) at day 1, than survivors. Here, FLT1 is linked to COVID-19.